 Catherine Lozupone
Concepts (393)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 25 | 2025 | 641 | 4.760 |
Why?
| | Bacteria | 40 | 2025 | 814 | 4.700 |
Why?
| | Microbiota | 22 | 2024 | 734 | 4.280 |
Why?
| | Phylogeny | 28 | 2020 | 845 | 2.550 |
Why?
| | Software | 10 | 2022 | 608 | 1.700 |
Why?
| | RNA, Ribosomal, 16S | 30 | 2025 | 524 | 1.690 |
Why?
| | HIV Infections | 18 | 2024 | 2730 | 1.640 |
Why?
| | Computational Biology | 8 | 2025 | 593 | 1.630 |
Why?
| | Metagenome | 13 | 2015 | 140 | 1.620 |
Why?
| | Feces | 17 | 2025 | 442 | 1.410 |
Why?
| | Gastrointestinal Tract | 13 | 2019 | 187 | 1.410 |
Why?
| | Biodiversity | 12 | 2018 | 380 | 1.340 |
Why?
| | Intestines | 8 | 2018 | 350 | 1.240 |
Why?
| | Interleukin-10 | 3 | 2022 | 304 | 1.230 |
Why?
| | Symbiosis | 6 | 2020 | 71 | 1.190 |
Why?
| | Dysbiosis | 5 | 2021 | 170 | 1.190 |
Why?
| | Anti-Retroviral Agents | 5 | 2024 | 231 | 0.980 |
Why?
| | Metabolome | 2 | 2019 | 339 | 0.950 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 196 | 0.790 |
Why?
| | Leukocytes, Mononuclear | 3 | 2022 | 546 | 0.770 |
Why?
| | Bacterial Toxins | 1 | 2022 | 104 | 0.740 |
Why?
| | Polysaccharides, Bacterial | 3 | 2022 | 67 | 0.720 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2025 | 326 | 0.710 |
Why?
| | Immune System | 2 | 2019 | 175 | 0.700 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 177 | 0.690 |
Why?
| | Blood Group Antigens | 1 | 2020 | 15 | 0.680 |
Why?
| | Ecosystem | 10 | 2017 | 561 | 0.670 |
Why?
| | Disease | 2 | 2019 | 94 | 0.670 |
Why?
| | Health | 2 | 2017 | 75 | 0.630 |
Why?
| | Parkinson Disease | 1 | 2025 | 462 | 0.630 |
Why?
| | Audiovisual Aids | 1 | 2019 | 13 | 0.620 |
Why?
| | Prevotella | 1 | 2018 | 14 | 0.610 |
Why?
| | Bacterial Infections | 2 | 2020 | 234 | 0.610 |
Why?
| | DNA, Bacterial | 7 | 2019 | 323 | 0.610 |
Why?
| | Dolphins | 1 | 2017 | 2 | 0.580 |
Why?
| | Anti-Inflammatory Agents | 2 | 2022 | 482 | 0.550 |
Why?
| | Genetic Techniques | 2 | 2008 | 62 | 0.530 |
Why?
| | Genetic Variation | 9 | 2011 | 937 | 0.530 |
Why?
| | Metagenomics | 5 | 2013 | 156 | 0.520 |
Why?
| | Soil Microbiology | 6 | 2011 | 211 | 0.520 |
Why?
| | Humans | 72 | 2025 | 129847 | 0.520 |
Why?
| | Sequence Analysis, DNA | 11 | 2017 | 778 | 0.480 |
Why?
| | Bacterial Physiological Phenomena | 5 | 2020 | 58 | 0.460 |
Why?
| | Immunotherapy | 1 | 2019 | 596 | 0.450 |
Why?
| | Immune Tolerance | 1 | 2016 | 356 | 0.440 |
Why?
| | Archaea | 3 | 2011 | 79 | 0.430 |
Why?
| | Animals | 35 | 2025 | 35409 | 0.430 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 373 | 0.420 |
Why?
| | Tropheryma | 1 | 2013 | 5 | 0.420 |
Why?
| | Biota | 1 | 2013 | 31 | 0.420 |
Why?
| | Whipple Disease | 1 | 2013 | 6 | 0.420 |
Why?
| | Obesity | 5 | 2021 | 2885 | 0.420 |
Why?
| | Ecology | 3 | 2011 | 111 | 0.400 |
Why?
| | Homosexuality, Male | 4 | 2022 | 176 | 0.380 |
Why?
| | Cluster Analysis | 8 | 2010 | 483 | 0.380 |
Why?
| | Microbiological Techniques | 2 | 2010 | 30 | 0.380 |
Why?
| | Liver Transplantation | 1 | 2019 | 833 | 0.370 |
Why?
| | Genes, Bacterial | 4 | 2011 | 159 | 0.350 |
Why?
| | Host-Pathogen Interactions | 5 | 2024 | 355 | 0.350 |
Why?
| | Molecular Sequence Data | 15 | 2013 | 2833 | 0.350 |
Why?
| | Genes, Archaeal | 1 | 2008 | 6 | 0.310 |
Why?
| | Glycosyltransferases | 1 | 2008 | 13 | 0.300 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 338 | 0.300 |
Why?
| | Inflammation | 5 | 2024 | 2748 | 0.300 |
Why?
| | Glycoside Hydrolases | 1 | 2008 | 33 | 0.300 |
Why?
| | Isoleucine | 2 | 2005 | 14 | 0.280 |
Why?
| | Hot Springs | 1 | 2007 | 7 | 0.270 |
Why?
| | Digestive System | 1 | 2007 | 29 | 0.270 |
Why?
| | Geologic Sediments | 1 | 2007 | 41 | 0.270 |
Why?
| | Germ-Free Life | 4 | 2025 | 33 | 0.260 |
Why?
| | Evolution, Molecular | 5 | 2012 | 462 | 0.250 |
Why?
| | Genome, Bacterial | 5 | 2021 | 134 | 0.240 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2019 | 260 | 0.240 |
Why?
| | RNA | 3 | 2012 | 877 | 0.240 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.230 |
Why?
| | Tea | 1 | 2025 | 20 | 0.230 |
Why?
| | Ciliophora | 2 | 2003 | 15 | 0.230 |
Why?
| | Cohort Studies | 9 | 2021 | 5444 | 0.230 |
Why?
| | Mice | 14 | 2025 | 16983 | 0.230 |
Why?
| | Neoplasms | 1 | 2019 | 2454 | 0.220 |
Why?
| | Zimbabwe | 1 | 2024 | 53 | 0.220 |
Why?
| | Receptors, CCR5 | 2 | 2021 | 57 | 0.220 |
Why?
| | Homeostasis | 2 | 2018 | 605 | 0.220 |
Why?
| | Body Mass Index | 4 | 2019 | 2274 | 0.210 |
Why?
| | Lung | 2 | 2013 | 3940 | 0.210 |
Why?
| | Internet | 2 | 2011 | 620 | 0.210 |
Why?
| | HIV | 2 | 2019 | 227 | 0.200 |
Why?
| | Bifidobacterium | 3 | 2017 | 21 | 0.200 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 13 | 0.200 |
Why?
| | Anti-Bacterial Agents | 3 | 2022 | 1708 | 0.200 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2018 | 486 | 0.190 |
Why?
| | Bacteroides | 3 | 2019 | 19 | 0.190 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 593 | 0.190 |
Why?
| | DNA, Ribosomal | 3 | 2013 | 82 | 0.190 |
Why?
| | Female | 25 | 2021 | 68829 | 0.190 |
Why?
| | Biological Evolution | 4 | 2009 | 435 | 0.180 |
Why?
| | Base Sequence | 9 | 2017 | 2142 | 0.180 |
Why?
| | Infant | 8 | 2021 | 9018 | 0.180 |
Why?
| | Environment | 3 | 2012 | 345 | 0.180 |
Why?
| | Metabolomics | 3 | 2025 | 652 | 0.180 |
Why?
| | Male | 22 | 2025 | 63759 | 0.180 |
Why?
| | Peptide Termination Factors | 1 | 2001 | 5 | 0.180 |
Why?
| | Genetic Code | 1 | 2001 | 20 | 0.180 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2020 | 267 | 0.180 |
Why?
| | Firmicutes | 1 | 2021 | 18 | 0.180 |
Why?
| | RNA, Bacterial | 4 | 2010 | 182 | 0.170 |
Why?
| | Sexual Behavior | 3 | 2020 | 481 | 0.170 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2020 | 11 | 0.170 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 7 | 0.170 |
Why?
| | Dietary Fats | 1 | 2022 | 303 | 0.170 |
Why?
| | Benzopyrans | 1 | 2019 | 25 | 0.160 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 110 | 0.160 |
Why?
| | Western World | 1 | 2019 | 7 | 0.160 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2021 | 1058 | 0.160 |
Why?
| | Hypersensitivity | 1 | 2022 | 249 | 0.160 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2020 | 123 | 0.160 |
Why?
| | Thiophenes | 1 | 2019 | 117 | 0.150 |
Why?
| | Liver Regeneration | 1 | 2019 | 40 | 0.150 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2724 | 0.150 |
Why?
| | Behavior Therapy | 1 | 2021 | 241 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2019 | 109 | 0.150 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2019 | 232 | 0.150 |
Why?
| | Sequence Analysis | 2 | 2009 | 36 | 0.150 |
Why?
| | Genes, rRNA | 4 | 2017 | 41 | 0.140 |
Why?
| | Transplantation, Homologous | 1 | 2019 | 402 | 0.140 |
Why?
| | Asthma | 3 | 2022 | 2225 | 0.140 |
Why?
| | Streptococcus | 1 | 2017 | 26 | 0.140 |
Why?
| | Mouth | 1 | 2017 | 84 | 0.140 |
Why?
| | Weight Gain | 2 | 2018 | 510 | 0.140 |
Why?
| | Microbial Consortia | 1 | 2017 | 18 | 0.130 |
Why?
| | Bacterial Load | 1 | 2017 | 67 | 0.130 |
Why?
| | Gene Transfer, Horizontal | 4 | 2010 | 29 | 0.130 |
Why?
| | Environmental Microbiology | 2 | 2007 | 48 | 0.130 |
Why?
| | Algorithms | 2 | 2022 | 1617 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 274 | 0.130 |
Why?
| | Disease Models, Animal | 5 | 2024 | 4077 | 0.130 |
Why?
| | Cholestasis | 1 | 2019 | 232 | 0.130 |
Why?
| | Leukemia | 1 | 2018 | 230 | 0.130 |
Why?
| | Life Style | 1 | 2018 | 462 | 0.130 |
Why?
| | Microbial Interactions | 1 | 2016 | 16 | 0.130 |
Why?
| | Adult | 14 | 2021 | 35634 | 0.120 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 706 | 0.120 |
Why?
| | Th17 Cells | 1 | 2016 | 85 | 0.120 |
Why?
| | Geography | 4 | 2012 | 189 | 0.120 |
Why?
| | Weight Loss | 1 | 2021 | 740 | 0.120 |
Why?
| | Pregnancy | 4 | 2017 | 6423 | 0.120 |
Why?
| | Diet | 3 | 2018 | 1212 | 0.120 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 198 | 0.120 |
Why?
| | Microbiology | 1 | 2015 | 24 | 0.120 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 240 | 0.120 |
Why?
| | Pediatric Obesity | 2 | 2019 | 573 | 0.110 |
Why?
| | Benchmarking | 1 | 2016 | 176 | 0.110 |
Why?
| | Probability | 1 | 2015 | 304 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 391 | 0.110 |
Why?
| | Genomics | 2 | 2011 | 716 | 0.110 |
Why?
| | Sequence Alignment | 2 | 2012 | 331 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2019 | 636 | 0.110 |
Why?
| | Colitis | 1 | 2016 | 245 | 0.110 |
Why?
| | Premature Birth | 1 | 2017 | 317 | 0.110 |
Why?
| | Infant, Newborn | 3 | 2020 | 5772 | 0.110 |
Why?
| | Anti-HIV Agents | 2 | 2017 | 757 | 0.100 |
Why?
| | Insulin Resistance | 2 | 2018 | 1168 | 0.100 |
Why?
| | Glucose | 1 | 2018 | 1003 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2017 | 463 | 0.100 |
Why?
| | Pets | 1 | 2013 | 25 | 0.100 |
Why?
| | Tongue | 1 | 2013 | 78 | 0.100 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 137 | 0.100 |
Why?
| | Clostridium | 1 | 2012 | 14 | 0.100 |
Why?
| | Autism Spectrum Disorder | 1 | 2017 | 386 | 0.100 |
Why?
| | Databases, Nucleic Acid | 1 | 2012 | 33 | 0.100 |
Why?
| | Colon | 2 | 2020 | 257 | 0.100 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 19 | 0.100 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1368 | 0.100 |
Why?
| | Cultured Milk Products | 1 | 2011 | 1 | 0.090 |
Why?
| | Housing | 1 | 2013 | 130 | 0.090 |
Why?
| | Fishes | 1 | 2012 | 94 | 0.090 |
Why?
| | Macaca mulatta | 2 | 2012 | 150 | 0.090 |
Why?
| | Mucin-5B | 1 | 2013 | 215 | 0.090 |
Why?
| | Antigens, CD | 2 | 2020 | 487 | 0.090 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2012 | 86 | 0.090 |
Why?
| | Methanobrevibacter | 1 | 2011 | 1 | 0.090 |
Why?
| | Middle Aged | 9 | 2021 | 31177 | 0.090 |
Why?
| | Genome, Archaeal | 1 | 2011 | 12 | 0.090 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2012 | 84 | 0.090 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 310 | 0.090 |
Why?
| | Child, Preschool | 7 | 2021 | 10522 | 0.090 |
Why?
| | Cameroon | 2 | 2021 | 8 | 0.090 |
Why?
| | Phenotype | 1 | 2019 | 3062 | 0.090 |
Why?
| | Adhesins, Bacterial | 1 | 2011 | 40 | 0.090 |
Why?
| | Adolescent | 9 | 2021 | 20451 | 0.090 |
Why?
| | Risk Factors | 3 | 2020 | 9801 | 0.090 |
Why?
| | RNA, Ribosomal | 2 | 2010 | 161 | 0.090 |
Why?
| | Behavioral Symptoms | 1 | 2011 | 42 | 0.090 |
Why?
| | HIV-1 | 2 | 2018 | 839 | 0.090 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 18 | 0.090 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2012 | 228 | 0.080 |
Why?
| | Child | 9 | 2022 | 20962 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2013 | 332 | 0.080 |
Why?
| | Comorbidity | 3 | 2022 | 1551 | 0.080 |
Why?
| | Young Adult | 7 | 2021 | 12467 | 0.080 |
Why?
| | Crohn Disease | 1 | 2013 | 217 | 0.080 |
Why?
| | Liver | 1 | 2018 | 1839 | 0.080 |
Why?
| | Twins | 1 | 2011 | 247 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5437 | 0.080 |
Why?
| | Genome | 2 | 2010 | 278 | 0.080 |
Why?
| | Fungi | 1 | 2010 | 136 | 0.080 |
Why?
| | Virus Replication | 2 | 2012 | 453 | 0.080 |
Why?
| | Viral Load | 3 | 2018 | 449 | 0.080 |
Why?
| | Family | 1 | 2013 | 646 | 0.080 |
Why?
| | CD4 Lymphocyte Count | 2 | 2021 | 267 | 0.080 |
Why?
| | Carbohydrates | 1 | 2008 | 64 | 0.070 |
Why?
| | Norway | 2 | 2018 | 42 | 0.070 |
Why?
| | Vertebrates | 1 | 2008 | 57 | 0.070 |
Why?
| | Skin | 1 | 2013 | 725 | 0.070 |
Why?
| | Lentivirus Infections | 1 | 2008 | 7 | 0.070 |
Why?
| | Enterocolitis | 1 | 2008 | 17 | 0.070 |
Why?
| | Monkey Diseases | 1 | 2008 | 20 | 0.070 |
Why?
| | Soil | 1 | 2010 | 226 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 195 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2045 | 0.070 |
Why?
| | Sequence Analysis, RNA | 1 | 2010 | 426 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 2481 | 0.070 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 171 | 0.070 |
Why?
| | Cytokines | 3 | 2021 | 2022 | 0.070 |
Why?
| | Adaptation, Biological | 1 | 2007 | 55 | 0.070 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 182 | 0.070 |
Why?
| | Demography | 1 | 2007 | 279 | 0.060 |
Why?
| | Models, Biological | 2 | 2013 | 1724 | 0.060 |
Why?
| | Biomarkers | 3 | 2017 | 3971 | 0.060 |
Why?
| | Viruses | 1 | 2007 | 100 | 0.060 |
Why?
| | Mammals | 1 | 2008 | 274 | 0.060 |
Why?
| | Twins, Monozygotic | 3 | 2012 | 209 | 0.060 |
Why?
| | Oligoribonucleotides | 1 | 2005 | 52 | 0.060 |
Why?
| | Adaptation, Physiological | 4 | 2011 | 521 | 0.060 |
Why?
| | Polymorphism, Genetic | 2 | 2010 | 636 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5468 | 0.060 |
Why?
| | DNA Primers | 2 | 2007 | 508 | 0.060 |
Why?
| | Neurotransmitter Agents | 2 | 2017 | 81 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2018 | 190 | 0.060 |
Why?
| | Species Specificity | 3 | 2011 | 568 | 0.050 |
Why?
| | DNA Polymerase I | 1 | 2003 | 29 | 0.050 |
Why?
| | Age Factors | 3 | 2018 | 3161 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1774 | 0.050 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 30 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 198 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 21 | 0.050 |
Why?
| | Recombination, Genetic | 1 | 2003 | 189 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 135 | 0.050 |
Why?
| | Interleukin-12 | 1 | 2022 | 118 | 0.050 |
Why?
| | Mental Disorders | 1 | 2011 | 1035 | 0.050 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 147 | 0.050 |
Why?
| | Mothers | 2 | 2018 | 731 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 138 | 0.050 |
Why?
| | Codon, Terminator | 1 | 2001 | 21 | 0.040 |
Why?
| | Protein Binding | 2 | 2005 | 2123 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 229 | 0.040 |
Why?
| | Twins, Dizygotic | 2 | 2012 | 181 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 60 | 0.040 |
Why?
| | Blastocystis hominis | 1 | 2020 | 1 | 0.040 |
Why?
| | Entamoeba | 1 | 2020 | 2 | 0.040 |
Why?
| | Cryptosporidium | 1 | 2020 | 13 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2012 | 1897 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 371 | 0.040 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 23 | 0.040 |
Why?
| | Methionine-tRNA Ligase | 1 | 2019 | 1 | 0.040 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 38 | 0.040 |
Why?
| | Aged | 5 | 2019 | 22107 | 0.040 |
Why?
| | Candida | 1 | 2020 | 37 | 0.040 |
Why?
| | Giardia lamblia | 1 | 2020 | 23 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2020 | 102 | 0.040 |
Why?
| | Clostridium Infections | 1 | 2019 | 64 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 201 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 45 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 349 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 998 | 0.040 |
Why?
| | Nucleotides | 2 | 2010 | 122 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 118 | 0.040 |
Why?
| | 2-Propanol | 1 | 2017 | 21 | 0.040 |
Why?
| | Databases, Genetic | 2 | 2011 | 228 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 766 | 0.040 |
Why?
| | Administration, Oral | 1 | 2019 | 787 | 0.030 |
Why?
| | Toll-Like Receptors | 1 | 2018 | 179 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1092 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2018 | 239 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2001 | 2057 | 0.030 |
Why?
| | Gene Library | 1 | 2017 | 115 | 0.030 |
Why?
| | Epigenomics | 1 | 2017 | 110 | 0.030 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2017 | 83 | 0.030 |
Why?
| | HIV Protease Inhibitors | 1 | 2017 | 68 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 613 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 7158 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 827 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 1089 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 163 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2016 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1877 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 306 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2018 | 505 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 391 | 0.030 |
Why?
| | Air Pollution | 1 | 2017 | 218 | 0.030 |
Why?
| | Allergens | 1 | 2017 | 385 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1110 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1269 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3384 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2013 | 70 | 0.030 |
Why?
| | Ear, Middle | 1 | 2013 | 91 | 0.030 |
Why?
| | Prevalence | 1 | 2020 | 2564 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1205 | 0.030 |
Why?
| | Overweight | 1 | 2017 | 531 | 0.030 |
Why?
| | Mutation | 1 | 2003 | 3706 | 0.020 |
Why?
| | Venezuela | 1 | 2012 | 7 | 0.020 |
Why?
| | Nucleotide Motifs | 1 | 2012 | 33 | 0.020 |
Why?
| | Malawi | 1 | 2012 | 49 | 0.020 |
Why?
| | Cilia | 1 | 2013 | 180 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 27 | 0.020 |
Why?
| | San Francisco | 1 | 2012 | 51 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 577 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 624 | 0.020 |
Why?
| | Dogs | 1 | 2013 | 385 | 0.020 |
Why?
| | Phagocytosis | 1 | 2013 | 362 | 0.020 |
Why?
| | Lactobacillus | 1 | 2011 | 26 | 0.020 |
Why?
| | Family Characteristics | 1 | 2013 | 180 | 0.020 |
Why?
| | Chronic Disease | 2 | 2008 | 1724 | 0.020 |
Why?
| | Programming Languages | 1 | 2011 | 23 | 0.020 |
Why?
| | Probiotics | 1 | 2011 | 51 | 0.020 |
Why?
| | Formates | 1 | 2011 | 14 | 0.020 |
Why?
| | United States | 2 | 2022 | 13913 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1271 | 0.020 |
Why?
| | Information Storage and Retrieval | 1 | 2011 | 108 | 0.020 |
Why?
| | Base Pairing | 1 | 2010 | 61 | 0.020 |
Why?
| | South America | 1 | 2010 | 58 | 0.020 |
Why?
| | Checklist | 1 | 2011 | 94 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2010 | 75 | 0.020 |
Why?
| | Ecological and Environmental Phenomena | 1 | 2009 | 6 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 541 | 0.020 |
Why?
| | Citrus | 1 | 2009 | 6 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2018 | 1937 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2010 | 227 | 0.020 |
Why?
| | DNA | 2 | 2007 | 1406 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 436 | 0.020 |
Why?
| | RNA, Transfer | 1 | 2010 | 130 | 0.020 |
Why?
| | North America | 1 | 2010 | 294 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5085 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 360 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2010 | 541 | 0.020 |
Why?
| | Carnivora | 1 | 2008 | 6 | 0.020 |
Why?
| | Animals, Zoo | 1 | 2008 | 12 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2011 | 245 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2135 | 0.020 |
Why?
| | Animals, Wild | 1 | 2008 | 54 | 0.020 |
Why?
| | Insulin | 1 | 2018 | 2330 | 0.020 |
Why?
| | Lentiviruses, Primate | 1 | 2008 | 13 | 0.020 |
Why?
| | Hand | 1 | 2009 | 157 | 0.020 |
Why?
| | Conjugation, Genetic | 1 | 2007 | 5 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 33 | 0.020 |
Why?
| | Gene Products, gag | 1 | 2007 | 36 | 0.020 |
Why?
| | Primates | 1 | 2008 | 120 | 0.020 |
Why?
| | Gene Duplication | 1 | 2007 | 67 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1033 | 0.020 |
Why?
| | Proteobacteria | 1 | 2007 | 15 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1488 | 0.020 |
Why?
| | BRCA1 Protein | 1 | 2007 | 65 | 0.020 |
Why?
| | von Willebrand Factor | 1 | 2007 | 71 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 119 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1951 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3397 | 0.020 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2007 | 186 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2007 | 310 | 0.020 |
Why?
| | Computer Simulation | 1 | 2010 | 941 | 0.020 |
Why?
| | Macrophages | 1 | 2013 | 1489 | 0.020 |
Why?
| | Bacteriophages | 1 | 2007 | 86 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1000 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 2005 | 83 | 0.020 |
Why?
| | Mice, Obese | 1 | 2005 | 63 | 0.020 |
Why?
| | B7-H1 Antigen | 1 | 2007 | 198 | 0.010 |
Why?
| | Ligands | 1 | 2007 | 621 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 2007 | 412 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2007 | 471 | 0.010 |
Why?
| | Cyanobacteria | 1 | 2005 | 51 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 836 | 0.010 |
Why?
| | DNA, Protozoan | 1 | 2003 | 26 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2007 | 773 | 0.010 |
Why?
| | Protein Conformation | 1 | 2007 | 861 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 151 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2062 | 0.010 |
Why?
| | Mosaicism | 1 | 2003 | 69 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2010 | 3089 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1251 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 474 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7066 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 855 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2378 | 0.010 |
Why?
| | Signal Transduction | 1 | 2007 | 4935 | 0.010 |
Why?
|
|
Lozupone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|